SANS FLUORO太大而不能倒。

Q3 Medicine

Journal of atrial fibrillation Pub Date : 2021-02-28 eCollection Date: 2021-02-01 DOI:10.4022/jafib.2453

Robert L Percell, Matthew E Johnson, Raghuveer Dendi

{"title":"SANS FLUORO太大而不能倒。","authors":"Robert L Percell, Matthew E Johnson, Raghuveer Dendi","doi":"10.4022/jafib.2453","DOIUrl":null,"url":null,"abstract":"We present the first ever reported case of a super morbidly obese patient (BMI > 60) with drug refractory, symptomatic persistent atrial fibrillation who underwent an uncomplicated, but unsuccessful PVI ablation procedure and subsequently underwent AV node ablation and cardiac resynchronization therapy - pacemaker (CRT-P) insertion using a zero fluoroscopy technique. This case demonstrates the following two critical points: (1) difficulties in the treatment of massively obese patients with arrhythmias1; (2) increased use of fluoroless procedures2-4.","PeriodicalId":15072,"journal":{"name":"Journal of atrial fibrillation","volume":" ","pages":"2453"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691357/pdf/jafib-13-02453.pdf","citationCount":"1","resultStr":"{\"title\":\"SANS FLUORO Too Big to Fail.\",\"authors\":\"Robert L Percell, Matthew E Johnson, Raghuveer Dendi\",\"doi\":\"10.4022/jafib.2453\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We present the first ever reported case of a super morbidly obese patient (BMI > 60) with drug refractory, symptomatic persistent atrial fibrillation who underwent an uncomplicated, but unsuccessful PVI ablation procedure and subsequently underwent AV node ablation and cardiac resynchronization therapy - pacemaker (CRT-P) insertion using a zero fluoroscopy technique. This case demonstrates the following two critical points: (1) difficulties in the treatment of massively obese patients with arrhythmias1; (2) increased use of fluoroless procedures2-4.\",\"PeriodicalId\":15072,\"journal\":{\"name\":\"Journal of atrial fibrillation\",\"volume\":\" \",\"pages\":\"2453\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691357/pdf/jafib-13-02453.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of atrial fibrillation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4022/jafib.2453\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of atrial fibrillation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4022/jafib.2453","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/2/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

我们报告了首例报道的伴有药物难治性、症状性持续性房颤的超级肥胖患者(BMI > 60)，他接受了无并发症但不成功的PVI消融手术，随后接受了房室结消融和心脏再同步化治疗-使用零透视技术插入起搏器(CRT-P)。本病例显示了以下两个关键点:(1)大量肥胖患者合并心律失常的治疗困难1;(2)增加使用无氟程序2-4。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

SANS FLUORO Too Big to Fail.

We present the first ever reported case of a super morbidly obese patient (BMI > 60) with drug refractory, symptomatic persistent atrial fibrillation who underwent an uncomplicated, but unsuccessful PVI ablation procedure and subsequently underwent AV node ablation and cardiac resynchronization therapy - pacemaker (CRT-P) insertion using a zero fluoroscopy technique. This case demonstrates the following two critical points: (1) difficulties in the treatment of massively obese patients with arrhythmias1; (2) increased use of fluoroless procedures2-4.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of atrial fibrillation Medicine-Cardiology and Cardiovascular Medicine

CiteScore

1.40

自引率

0.00%

发文量